Cannabis Approvals up 1000% year on year

FreshLeaf Analytics, a Southern Cannabis Holdings (SCH) division, has released Australia’s most comprehensive medicinal cannabis Patient, Product and Pricing Analysis.

The study was conducted in Q3 2019 and includes insights into the pricing and availability of legal medicinal cannabis products in the Australian marketplace including:

  • Number of products in market jumps 40% in 6 months

  • Patient growth continues at break-neck speed, up 1000% year on year

  • Overall spend declines as doctors go for cheaper products

  • Issues around vehicle driving and government subsidies remain

The report has been welcomed by the sector, with key players

/Public Release.